Icon

NEXIUM IV (nda021689)- (EQ 20MG BASE/VIAL,EQ 40MG BASE/VIAL)

ESOMEPRAZOLE SODIUM ASTRAZENECA
EQ 20MG BASE/VIAL,EQ 40MG BASE/VIAL
Yes No
2015-May-27 Expired
None None
None No
NEXIUM I.V. is a proton pump inhibitor (PPI) indicated for the: • Short-term treatment of Gastroesophageal Reflux Disease (GERD) with erosive esophagitis (EE) in adults and pediatric patients 1 month to 17 years of age, as an alternative to oral therapy when oral NEXIUM is not possible or appropriate. • Risk reduction of rebleeding of gastric or duodenal ulcers following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers in adults.
7 0 4
Total Other Developers None
Drugs with Suitability No
EQ 20MG BASE/VIAL ** ** - - -
EQ 40MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** *** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ****, *****, ***, ************, ********** ******, **********, ********* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ****** **** ****** **** *****. **., ***. *********** ********** ******** *********** ****, ****** ********, ******, ****** ******, ***** (***) ***
****** ****** **** ****** **** *****. **., ***. *** *********** ********** ******** *********** ****, ****** ********, ******, ****** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.